<?xml version="1.0" encoding="UTF-8"?>

<MedicationRequest xmlns="http://hl7.org/fhir">
  <id value="mii-exa-mtb-therapieempfehlung-dabrafenib"/>
  <meta>
    <profile value="https://www.medizininformatik-initiative.de/fhir/ext/modul-mtb/StructureDefinition/mii-pr-mtb-therapieempfehlung|2026.0.1"/>
  </meta>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: MedicationRequest mii-exa-mtb-therapieempfehlung-dabrafenib</b></p><a name="mii-exa-mtb-therapieempfehlung-dabrafenib"> </a><a name="hcmii-exa-mtb-therapieempfehlung-dabrafenib"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-mii-pr-mtb-therapieempfehlung.html">MII PR MTB Therapieempfehlung Systemische Therapieversion: null2026.0.1)</a></p></div><p><b>status</b>: Active</p><p><b>intent</b>: Option</p><p><b>medication</b>: <span title="Codes:{http://fhir.de/CodeSystem/bfarm/atc L01EC02}">Dabrafenib</span></p><p><b>subject</b>: <a href="Patient-mii-exa-mtb-patient.html">Maxim Muster  (no stated gender), DoB Unknown</a></p><p><b>authoredOn</b>: 2024-01-01</p><p><b>reasonReference</b>: <a href="Condition-PatientKimMusterperson-PrimaryDiagnosis-2.html">Condition Bösartige Neubildung: Peritoneum, nicht näher bezeichnet</a></p></div>
  </text>
  <status value="active"/>
  <intent value="option"/>
  <medicationCodeableConcept>
    <coding>
      <system value="http://fhir.de/CodeSystem/bfarm/atc"/>
      <version value="2025"/>
      <code value="L01EC02"/>
      <display value="Dabrafenib"/>
    </coding>
  </medicationCodeableConcept>
  <subject>
    <reference value="Patient/mii-exa-mtb-patient"/>
  </subject>
  <authoredOn value="2024-01-01"/>
  <reasonReference>
    <reference value="Condition/PatientKimMusterperson-PrimaryDiagnosis-2"/>
  </reasonReference>
</MedicationRequest>